Track topics on Twitter Track topics that are important to you
SciFluor Life Sciences, a Boston-based developer of technology for adding fluorine to organic molecules such as pharmaceutical drugs and commercial chemicals, launched today with $5 million in funding from Allied Minds. The technology, which helps make molecules more stable, potent, and better able to penetrate the blood-brain barrier, comes from Harvard University’s professor Tobias Ritter [...]
Original Article: SciFluor Kicks Off With $5MNEXT ARTICLE
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase 'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...